COVID-19 IP Catch-Up: Remdesivir Access, Zoom TM Security
The novel coronavirus pandemic has continued to cause delays and waivers in the patent and trademark worlds, and also has led to questions about who owns the rights to a key...To view the full article, register now.
Already a subscriber? Click here to view full article